[Current therapeutics 2000].
The most important drugs registered and/or launched in Belgium during the last year in the various disciplines of internal medicine will be briefly described. The originality of each molecule as well as its modalities of appropriate use in clinical practice will be emphasized.
Scheen
A J
AJ
Service de Diabétologie, Université de Liège.
D000890:Anti-Infective Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001530:Belgium; D002491:Central Nervous System Agents / Q000627:therapeutic use; D004358:Drug Therapy / Q000145:classification; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019141:Respiratory System Agents / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D018501:Antirheumatic Agents; D002491:Central Nervous System Agents; D005765:Gastrointestinal Agents; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D019141:Respiratory System Agents